LEADER 01976nam  2200361   450 
001 9910688302703321
005 20230624071423.0
035   $a(CKB)5400000000043773
035   $a(NjHacI)995400000000043773
035   $a(EXLCZ)995400000000043773
100   $a20230624d2021      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aPlasmodium Species and Drug Resistance /$fedited by Rajeev Tyagi
210  1$aLondon, England :$cIntechOpen,$d2021.
215   $a1 online resource (286 pages)
311   $a1-83969-257-X 
330   $aAs teachers of parasite biology, we are becoming increasingly aware of the lack of detailed information and experimental approaches about drugs and drug resistance in many medical schools and undergraduate courses. Therefore, this book discusses parasite biology, antimalarial drugs and their mechanism of action, and the dynamic situation of evolving drug resistance of parasites, which has become a pressing issue. It provides insight into the plasmodium species, the role of cytokines in activating immune response during malaria infection, the importance of antimalarials as a therapeutic option, issues of drug resistance and co-resistance, and validation of evolved resistance in humanized mouse models. It is a timely addition to the existing literature on malaria parasite biology and a useful resource for students, researchers, and those working in the field of parasite biology, drugs, drug resistance of infectious diseases in general, and human malaria parasites in particular and beyond.
606   $aPharmacology
606   $aDrugs
615  0$aPharmacology.
615  0$aDrugs.
676   $a615.1
702   $aTyagi$b Rajeev K.
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910688302703321
996   $aPlasmodium Species and Drug Resistance$92822495
997   $aUNINA